Sjögren’s Syndrome News

There are several differences in the symptoms reported among male and female patients with primary Sjögren’s syndrome, according to data published in the Journal of Clinical Rheumatology.

EULAR has initiated a survey that will collect data directly from patients on the impact and outcomes of rheumatic and musculoskeletal diseases, according to a statement released during the EULAR 2023 Congress.

Properly managing cardiovascular disease in patients with immune-mediated inflammatory diseases requires following guidelines and inter-specialty collaboration, according to a speaker at the Biologic Therapies Summit.

DESTIN, Fla. — Multiple potentially new therapies promise to improve the management of patients with Sjӧgren’s syndrome, according to a speaker at the 2023 Congress of Clinical Rheumatology meeting.

DESTIN, Fla. — Stratifying Sjögren’s disease patients by symptoms or biologic parameters may help rheumatologists hit therapeutic targets, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.

In rheumatology, there is no shortage of conditions that are difficult to diagnose, with diseases like fibromyalgia and systemic lupus erythematosus sometimes taking years before being officially identified — leading to adverse outcomes.

Patients with pulmonary arterial hypertension associated with connective tissue disease demonstrate a “poor” 10-year rate of 59.9%, according to data published in Rheumatology.

The presence of anti-SSA/RO antibodies in pregnant patients can predict adverse pregnancy outcomes, including spontaneous abortion, according to data published in Pediatric Rheumatology.

A novel, fully automated multiparametric autoantibody analysis may improve the early diagnosis of connective tissue diseases, particularly lupus and Sjögren’s syndrome, according to data published in Arthritis Research & Therapy.

Dazodalibep has successfully improved disease activity and symptoms two patient populations with Sjögren’s syndrome in a phase 2 trial, according to a press release from Horizon Therapeutics.